Clinical Trials Browser

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type

NCT06540144 2026-02-27

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Phase 3 Enrolling by invitation

12 enrolled

Myasthenia Gravis

NCT06624189 2026-02-27

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Enrolling by invitation

1,300 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT07053813 2026-02-27

CARE-HCS

Phase NA Enrolling by invitation

900 enrolled

Neoplastic Syndromes, Hereditary

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Enrolling by invitation

100 enrolled

GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Enrolling by invitation

120 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

1,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07158450 2026-02-25

NOECHO

Enrolling by invitation

50 enrolled

Heart Failure, Cardiotoxicity

NCT07400835 2026-02-24

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Enrolling by invitation

600 enrolled

Gynecologic

Endometrial Neoplasms

NCT07429760 2026-02-24

Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery

Phase NA Enrolling by invitation

60 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05303532 2026-02-23

ROSY-D

Phase 3 Enrolling by invitation

214 enrolled

Tumor-Agnostic

Neoplasms

NCT07422727 2026-02-20

COOLVAS

Phase NA Enrolling by invitation

40 enrolled

Neoplasms, Hot Flashes

NCT05369611 2026-02-19

COVID-19 Experiences in the SELF Cohort

Enrolling by invitation

1,668 enrolled

COVID-19, Leiomyoma

NCT06388252 2026-02-19

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

Phase NA Enrolling by invitation

10 enrolled

Dermatologic

Melanoma, Cutaneous Malignant

NCT06412029 2026-02-19

HRSN

Enrolling by invitation

144 enrolled

Tumor-Agnostic

Neoplasms

NCT04693754 2026-02-18

EUS-RFA

Enrolling by invitation

100 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

Development and Application of Patient-Derived Models of Cancer

Natural History Study of Early Life Exposures in Agriculture (ELEA)

NeoMARS

Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

PERSIST

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

ziMyG+

Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors

Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy

LTFS

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Harvesting Cells for Experimental Cancer Treatments

ablation IN BE

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

IMPACTT

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

Self-Management Support for Lung Cancer Patients With Cachexia

FasteStudien

VascuLens RCT

Collection of Blood and Urine From Patients Undergoing Radiation Therapy

OPTIMA

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

J21112LINKED

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

CPHMS

ECA-PRO Aim 3

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

AFFEPAM

CONQUER

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

LEO

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

CARE-HCS

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

NOECHO

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery

ROSY-D

COOLVAS

COVID-19 Experiences in the SELF Cohort

Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients

HRSN

EUS-RFA